The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM
The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM
Enrolling by invitation · NCT06616727 · Registry updated 2024-09-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Enrolling by invitation | Phase 1 | 2024-09-27 | NCT06616727 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Simnova Biotechnology Co.,Ltd. | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chinese PLA General Hospital | Beijing | China | 39 |